Find your path to Paul
468 people in our graph can introduce you to Paul.
Sign up to see every warm intro you have to Paul
- Paths you didn't know you had: your email and LinkedIn already hold routes to Paul. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Experience
- Raven Healthcare Incubator (RA Capital)Venture Partnercurrent2026 — presentBoston, Massachusetts, United States
- Mediar TherapeuticsScientific Advisorcurrent2026 — presentBoston, Massachusetts, United States
- Mediar TherapeuticsChief Scientific Officer2019 — 2026Boston, Massachusetts, United States
- Three Lakes 12-20Advisory Board Membercurrent2025 — present
- WEST - Women in the Enterprise of Science and TechnologyAdvisory Board Member2023 — 2025
- PfizerChief Operating Officer, Inflammation & Immunology Research2012 — 2019Cambridge, MA
- PfizerDirector, Inflammation & Remodeling Research, Fibrosis Disease Area Lead2011 — 2012Cambridge, MA
- PfizerDirector, Tissue Repair Research2010 — 2011Cambridge, MA
- PfizerAssociate Director, Muscle Research, Women's Health & Musculoskeletal Biology (Wyeth)2006 — 2009Cambridge, MA
- PfizerPrincipal Scientist II, Biological Technologies (Wyeth)2006Cambridge, MA
- PfizerPrincipal Scientist I, Biological Technologies (Wyeth)2002 — 2005Cambridge, MA
- PfizerStaff Scientist II, Genomics (Wyeth)2001 — 2002Cambridge, MA
- PfizerStaff Scientist I, Genomics (Wyeth)1999 — 2000Cambridge, MA
- PfizerPostdoctoral Fellow (Genetics Institute)1998 — 1999Cambridge, MA
Skills & more
Drug Discovery52Drug Development40Biotechnology32Life Sciences30Biomarkers24Immunology26Assay Development16Clinical Development15Molecular Biology13Genomics9Inflammation11Translational Medicine5
+10 more
AntibodiesOncologyBiopharmaceuticalsCell CultureCellProtein ChemistryPharmacologyMonoclonal AntibodiesStrategyPharmaceutical IndustryFrom Paul's professional profile.
Colleagues at RA Capital
Abigail Greely
IT Business Analyst at RA Capital
Abigail Schmitz
Senior Associate, Corporate Development at RA Capital
Adam Kaye
Senior Managing Director and Partner, Structured Capital at RA Capital
Adam Prince
Senior Associate, Strategic Initiatives at RA Capital
Adam Travis
Vice President, Corporate Development at RA Capital
Adison Greene
Senior Executive Assistant at RA Capital
Adrian Bot
Venture Partner at RA Capital
Alana MacDonald
Senior Associate at RA Capital
Frequently asked questions
- Who is Paul Yaworsky?
- Venture Partner at RA Capital
- Where does Paul Yaworsky work?
- Paul Yaworsky is Venture Partner at RA Capital.
- Where did Paul Yaworsky go to school?
- Paul Yaworsky studied at MIT Sloan School of Management (Certificate, Strategy and Innovation); Mayo Clinic Graduate School of Biomedical Sciences (PhD, Molecular Neuroscience); University of Toronto - University College (BSc, Molecular Genetics).
Same school
Also attended MIT Sloan School of Management1,030
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsChris MorrisProcess Specialist, Exit Readiness at Mayfair Equity PartnersBirgitteInvestor at InvestinorOla SmebyInvestor at Investinor
+ 1,024 more
Also attended Mayo Clinic Graduate School of Biomedical Sciences5
Also attended University of Toronto - University College10
Frederik GroenewegenGeneral Partner at 415 CapitalJessica PalterChief Legal Officer at Purpose InvestmentsTihomir BajicManaging Partner, X& at Leaders FundMark TerrillPeer Forum Facilitator at InterGen CapitalRyan HenryPartner at Sand Hill North VenturesAriel GartenCo-founder and Chief Evangelism Officer at Interaxon
+ 4 more
Shared employers
Also worked at Raven Healthcare Incubator (RA Capital)36
Peyman HosseinchiSenior Associate at JDRF T1D FundSonia KarthaAssociate at RA CapitalHugo Arellano-SantoyoInvestor at RAVen (RA Ventures)James StankowiczHead of AI & Engineering at Luma GroupJosh ResnickPartner at RA CapitalRamin Farzaneh-FarVenture Partner at RA Capital
+ 30 more
Also worked at Mediar Therapeutics10
Adam CottonPrincipal at the Novartis Venture FundAnja KoenigGlobal Head of NVF at Novartis Venture FundChristoph KocherPrincipal at GimvAndreas JurgeitPartner at GimvRobert DrakasPresident at ShangPharma InnovationBharat SrinivasaPrincipal at Amplitude Venture Capital
+ 4 more
Also worked at WEST - Women in the Enterprise of Science and Technology4
Also worked at Pfizer422
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission Biocapital
+ 416 more
















































